The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the way that i think about apoe4 is it increases vascular risk it increases the likelihood of a bad pathologic protein called amyloid it's a sticky stuff that builds up in the brain of a person with alzheimer's and people with this gene are more likely to have accelerated deposition or accelerated accumulation of this amyloid protein through a what i would call just in a basic sense a a cholesterol-like vascular-like pathway
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.